BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29336235)

  • 1. Rapid Remission of Graves' Hyperthyroidism Without Thionamides Under Immunosuppressive Treatment for Concomitant Autoimmune Hepatitis.
    Papadakis GE; Lamine F; Chtioui H; Moschouri E; Christinet MF; Marino L; Favre L; Sciarra A; Sempoux C; Schneider A; Duss FR; Sartori C; Moradpour D; Sykiotis GP
    Thyroid; 2018 Feb; 28(2):276-278. PubMed ID: 29336235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Graves' disease and liver abnormalities: antithyroid drugs are not the only factors involved!].
    Zabulon A; Gelu-Simeon M; Bélia L; Chingan V; Duflo S; Vélayoudom-Céphise FL
    Presse Med; 2015 Jan; 44(1):110-2. PubMed ID: 25530575
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?
    Laurberg P
    Eur J Endocrinol; 2006 Dec; 155(6):783-6. PubMed ID: 17132745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune hepatitis associated with Graves' disease.
    Cui B; Abe M; Hidata S; Nakanishi S; Matsuura B; Michitaka K; Yamamoto K; Horiike N; Onji M
    Intern Med; 2003 Apr; 42(4):331-5. PubMed ID: 12729321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.
    Tütüncü NB; Tütüncü T; Ozgen A; Erbas T
    J Natl Med Assoc; 2006 Jun; 98(6):926-30. PubMed ID: 16775915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
    Kinjo Y; Takasu N; Komiya I; Tomoyose T; Takara M; Kouki T; Shimajiri Y; Yabiku K; Yoshimura H
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2593-6. PubMed ID: 12050220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of early immunosuppressive therapy in the prevention of complications of Graves' disease].
    Huszno B; Trofimiuk M; Gołkowski F; Plinta T; Szybiński Z
    Przegl Lek; 2004; 61(8):868-71. PubMed ID: 15789920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission after potassium iodide therapy in patients with Graves' hyperthyroidism exhibiting thionamide-associated side effects.
    Okamura K; Sato K; Fujikawa M; Bandai S; Ikenoue H; Kitazono T
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3995-4002. PubMed ID: 25144628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome Prediction of Treatment of Graves' Hyperthyroidism with Antithyroid Drugs.
    Piantanida E; Lai A; Sassi L; Gallo D; Spreafico E; Tanda ML; Bartalena L
    Horm Metab Res; 2015 Sep; 47(10):767-72. PubMed ID: 26197855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polyarthritis not related to thionamides as complication of Graves' disease].
    Chávez López M; Valdivia López J; Delgado Villafaña J
    An Med Interna; 2005 Nov; 22(11):554-5. PubMed ID: 16498736
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
    Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease.
    Sipe WE; Su M; Posselt A; Kim GE; Quiros JA; Rosenthal P
    Pediatr Transplant; 2006 Jun; 10(4):525-8. PubMed ID: 16712616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing remission rates using antithyroid drugs for Graves' disease.
    Hegedüs L
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):729-30. PubMed ID: 20050856
    [No Abstract]   [Full Text] [Related]  

  • 18. [The course of diffuse hyperthyroidism in Basedow disease].
    Schifferdecker E
    Fortschr Med; 1990 Jan; 108(1):42-4. PubMed ID: 1690164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Primary Biliary Cirrhosis-autoimmune Hepatitis Overlap Syndrome with Immune Thrombocytopenia and Graves' Disease.
    Koyamada R; Higuchi T; Kitada A; Nakagawa T; Ikeya T; Okada S; Fujita Y
    Intern Med; 2015; 54(16):2013-6. PubMed ID: 26278293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.